RBC Europe’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,115
Closed -$960K 865
2021
Q3
$960K Hold
4,115
0.04% 141
2021
Q2
$847K Hold
4,115
0.04% 158
2021
Q1
$845K Hold
4,115
0.05% 149
2020
Q4
$883K Hold
4,115
0.05% 144
2020
Q3
$752K Hold
4,115
0.05% 140
2020
Q2
$758K Hold
4,115
0.06% 136
2020
Q1
$830K Sell
4,115
-109
-3% -$21K 0.08% 112
2019
Q4
$790K Hold
4,224
0.07% 129
2019
Q3
$674K Sell
4,224
-273
-6% -$54.3K 0.07% 138
2019
Q2
$1.13M Hold
4,497
0.11% 112
2019
Q1
$1.08M Hold
4,497
0.12% 110
2018
Q4
$1.03M Hold
4,497
0.13% 99
2018
Q3
$1.27M Hold
4,497
0.14% 104
2018
Q2
$1.32M Hold
4,497
0.16% 97
2018
Q1
$1.14M Sell
4,497
-43
-0.9% -$10.1K 0.14% 108
2017
Q4
$981K Hold
4,540
0.12% 107
2017
Q3
$844K Buy
+4,540
New +$792K 0.11% 117

Other funds holding ICUI

RBC Europe's ICUI Position: Q4 2021 in Review

RBC Europe sold out of ICU Medical (ICUI) in Q4 2021, closing a stake of 4,115 shares — an estimated $960K sold.

RBC Europe first reported a position in ICUI in Q3 2017 and held it in 17 quarters. The position peaked at $1.32M in Q2 2018. 294 funds tracked by Wall St. Rank hold ICUI as of Q4 2021.

  • RBC Europe reported no remaining ICU Medical position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 4,115 ICU Medical shares in Q4 2021, an estimated $960K.
  • RBC Europe first reported a position in ICU Medical in Q3 2017 and held it in 17 quarters.
  • RBC Europe's ICU Medical position peaked at $1.32M in Q2 2018.
  • 294 funds tracked by Wall St. Rank held ICU Medical as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.